Trinity Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.34	5.17	3.69	6.58	25.91	27.33
Cash & Short-Term Investments	1.34	5.17	3.69	6.58	25.91	27.33
Cash Growth	-52.78%	39.99%	-43.89%	-74.61%	-5.18%	66.63%
Accounts Receivable	14.49	13.88	11.34	13.45	14.17	21.42
Other Receivables	0.53	0.73	1.67	2.21	1.54	3.18
Receivables	15.02	14.6	13.01	15.66	15.71	24.6
Inventory	19.16	19.37	19.93	22.5	29.12	30.22
Prepaid Expenses	-	1.98	2.04	1.93	1.95	1.16
Other Current Assets	-	-	0.37	-	-	-
Total Current Assets	35.52	41.12	39.04	46.67	72.69	83.3
Property, Plant & Equipment	4.01	4.62	1.89	5.68	5.92	8.55
Long-Term Investments	2.76	2.46	-	-	-	-
Goodwill	-	13.84	-	12.54	12.54	12.59
Other Intangible Assets	57.81	16.55	1.17	5.72	5.77	7.83
Long-Term Accounts Receivable	-	-	0.04	0.08	0.15	0.29
Long-Term Deferred Tax Assets	3.55	3.55	1.98	4.22	4.1	4.18
Long-Term Deferred Charges	-	20.95	15.1	17.01	17.68	13.44
Other Long-Term Assets	0.06	0.19	0.22	0.18	0.06	0.21
Total Assets	103.71	103.29	59.44	92.1	118.9	130.4
Accounts Payable	30.36	6.83	3.89	6.21	6.76	7.1
Accrued Expenses	-	14.37	8.07	9.06	8.12	9.69
Short-Term Debt	-	-	-	-	-	2.91
Current Portion of Long-Term Debt	0.21	0.21	0.21	0.21	83.31	-
Current Portion of Leases	2.13	2.29	1.69	1.68	1.98	2.15
Current Income Taxes Payable	0.49	0.36	0.28	0.03	0.02	0.15
Current Unearned Revenue	-	0.2	0.05	0.11	0.21	4.45
Other Current Liabilities	1.31	7.84	0.85	0.05	0.08	0.61
Total Current Liabilities	34.49	32.1	15.04	17.34	100.49	27.06
Long-Term Debt	104.78	87.79	54.65	58.05	-	82.7
Long-Term Leases	10.08	10.48	10.87	12.27	13.87	16.59
Long-Term Deferred Tax Liabilities	4.56	4.56	2.3	5.06	4.86	4.91
Other Long-Term Liabilities	4.51	3.55	0.53	1.57	-	1.37
Total Liabilities	158.43	138.47	83.38	94.28	119.21	132.62
Common Stock	0.04	4.19	1.97	1.96	1.21	1.21
Additional Paid-In Capital	63.85	63.4	46.62	46.46	16.19	16.19
Retained Earnings	-98.73	-79.12	-48.64	-26.7	12.56	10.57
Treasury Stock	-24.92	-24.92	-24.92	-24.92	-24.92	-24.92
Comprehensive Income & Other	5.05	1.27	1.03	1.02	-5.36	-5.27
Shareholders' Equity	-54.72	-35.18	-23.95	-2.18	-0.32	-2.22
Total Liabilities & Equity	103.71	103.29	59.44	92.1	118.9	130.4
Total Debt	117.2	100.76	67.43	72.2	99.16	104.34
Net Cash (Debt)	-115.86	-95.6	-63.74	-65.62	-73.25	-77.01
Net Cash Per Share	-4.70	-5.32	-8.33	-9.73	-17.52	-18.42
Filing Date Shares Outstanding	18.66	18.63	9.47	7.64	5.38	4.18
Total Common Shares Outstanding	18.66	17.96	7.67	7.62	4.18	4.18
Working Capital	1.02	9.03	24.01	29.33	-27.8	56.24
Book Value Per Share	-2.93	-1.96	-3.12	-0.29	-0.08	-0.53
Tangible Book Value	-112.53	-65.57	-25.12	-20.44	-18.62	-22.64
Tangible Book Value Per Share	-6.03	-3.65	-3.28	-2.68	-4.45	-5.41
Land	-	26.78	24.27	24.68	24.33	24.29
Machinery	-	41.03	39.04	38.22	36.54	38.15
Leasehold Improvements	-	2.81	2.76	2.7	2.59	2.67

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q